Shortened Telomere Length as a Risk Factor for Idiopathic Pulmonary Fibrosis: A Meta-Analysis

Area of Science:

• Pulmonary Medicine
• Genetics
• Cellular Biology

Background:

• Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease with a poor prognosis, often diagnosed late.
• Telomere shortening, influenced by specific genes, is implicated in a significant proportion of IPF cases.
• Understanding the role of telomere length in IPF pathogenesis is crucial for improving patient outcomes.

Purpose of the Study:

• To systematically review and analyze the association between short telomere length and the incidence of Idiopathic Pulmonary Fibrosis.
• To determine if telomere length serves as a risk factor or predictive biomarker for IPF.

Main Methods:

• A systematic literature search was performed across PubMed, Scopus, and Cochrane databases.
• Six original studies, including case-control and cohort designs with 622 IPF patients and 544 controls, were included in a meta-analysis.
• Pooled analysis utilized a random-effect model to calculate the standard mean difference (SMD) in telomere length between IPF patients and controls.

Main Results:

• IPF patients exhibited significantly shorter telomere lengths compared to healthy controls (SMD: -0.84, 95% CI -1.21 to -0.48, p < 0.00001).
• Subgroup analysis indicated more pronounced telomere shortening in lung tissue samples than in peripheral blood samples.
• These findings strongly suggest a close association between telomere length and the pathogenesis of pulmonary fibrosis.

Conclusions:

• Shorter telomere lengths are significantly associated with Idiopathic Pulmonary Fibrosis, identifying telomere length as a potential risk factor.
• Telomere length assessment may offer value for early IPF detection and serve as a predictive biomarker for clinical outcomes.
• Further research into telomere dynamics could elucidate IPF mechanisms and inform therapeutic strategies.